Introduction
Priestley (1775, see Chapter 1), the discoverer of oxygen, theorized about the effects of hyperoxia in this charming passage:
We may also infer from these experiments, that though pure dephlogisticated air might be very useful as a medicine, it might 110tbe so properfor use in the healthy state of the body: for, as a cal1dle bums out much faster in dephlogisticated than in COlllmOI1 air, so we might, as might be said, live out too fast, and the al1imal powers be too SOOI1 exhausted il1 this pure kind of air. A moralist, at least, may say that the air which l1ature has provided for us is as good as we deserve.
Paul Bert ( 1878, see Chapter 1) was the first to actually document the toxicity of oxygen. He conducted experiments to test the effects of hyperbaric oxygen (HBO), not only on himself but also on other life forms. Indeed, seizures resulting from the toxicity of oxygen to the central nervous system are still referred to as the "Paul Bert effect." Although his work is a classic, Bert com pletely missed pulmonary toxicity as an effect of normobaric oxygen. This was later discovered by Lorraine Smith (1899) and is fittingly referred to as the "Lorraine Smith effect." Bean (1945) studied the toxic effects of continuous e:x.'P0sure to HBO beyond the point of seizures, to irreversible neurological damage and eventual death; this problem is now widely known as the "John Bean effect. " Behnke et al (1936) carried out a variety of experiments in human subjects to show the effects of oxygen toxicity. As a result of these earlier studies it became generally accepted that a 3-h exposure at 3 ATA and a 30-to 40-min exposure at 4 ATA were the limits of safe tolerance by healthy human adults. It is now generally accepted that HBO at 3 ATA affects primarily the nervous system, while the respiratory system is affected independently at 2 ATA. There is a vast amount of literature on basic mechanism of oxygen toxicity (Bean 1945; Balentine 1982) .
This chapter describes mainly the toxic effects of HBO.
Normobaric hyperoxia, which usually leads to pulmonary oxygen poisoning, has been dealt with in detail elsewhere (Jain 1989a).
Pathophysiology of Oxygen Toxicity
The molecular basis of CNS as well as pulmonary oxygen poisoning, involves generation of reactive oxygen species (ROS). This has been known as the free radical theory of oxygen poisoning. The basis of this theory, for the CNS o:x.l'gentoxicity, is that an increased generation ofROS during HBO may ultimately lead to alterations in cerebral energy metabolism and electrical activity due to membranes lipid peroxidation, enzyme inhibition, and/or enzyme modulation. Although HBO-induced generation of ROS could directly alter the functions of various SH-containing enzymes, membrane-bound enzymes and structures as well as the nucleus, the physiological effects of HBO may also indirectly cause hypoxic-ischemia, acidosis, anemia, and hyperbilirubinemia.
At higher pressures of oxygen, events in the brain are a prelude to a distinct lung pathology. The experimental observation that CNS-mediated component of lung injury can be attenuated by selective inhibition of neuronal nitric oxide synthase (nNOS) or by unilateral transection of the vagus nerve has led to the hypothesis that extrapulmonary, neurogenic events predominate in the pathogenesis of acute pulmonary oxygen toxicity in HBO, as nNOS activity drives lung injury by modulating the output of central autonomic pathways (Demchenko et al 2007) .
Free Radical Mechanisms
Oxygen free radicals are products of normal cellular oxidation-reduction processes. Under conditions of hyperoxia, their production increases markedly. The nature of the ox- ygenmoleculemakes it susceptible to univalent reduction reactions in the cells to form superoxide anion (02-) a highlyreactivc, cytotoxic free radical. In turn, other reaction productsof oxygen metabolism, including hydrogen peroxide (H20Z), hydroA")'1 radicals (OH·), and singlet oxygen (IO~), can he formed. These short-lived forms are capable ofoxidizingthe sulfhydryl (SH) groups of enzymes, interactwithDNA, and promote lipoperoxidation of cellular membrancs. Animal studies showing the effect of HBO in raising thccerebral peroxide content and correlating it with C;-':S toxicityare listed in Table 6 .1.
Boveris and Chance presented an excellent unifying concrptof thc mechanism of oxygen toxicity in 1978, which is aclassic now.H20Z generation as a physiological event has orendocumented in a variety of isolated mitochondria and israpidlyenhanced by hyperoxia. Superoxide ions, generatedsubmitochondrial fractions, are the source of H202 (Bo\'eris & Chance 1978) . This hypothesis is shown in Figurr6 .1. Asa primary event, the free radical chain reactions produce lipoperoxidation. Lipoperoxides, in turn, will have disruptivc effects on the structure of the biomembranes, inhibit enzymes with SH groups, and shift the cellular redmstateof glutathione toward oxidation. This will be tranImitted through the secondary events to pyridine nucleotides, withthe mitochondrial NAD H oxidation resulting in impaired energy production. Enzyme inhibition, altered energy production, and decrease or loss of function may be consequences of either increased peroxides or a decline in the antioxidant defence.
Although increased generation of ROS before the onset of HBO-induced convulsions has been demonstrated in conscious rats, their production in association with oxygen toxicity has not been demonstrated satisfactorily in human subjects. There are increased electron spin resonance signals from blood of persons exposed to HBO but these return to normal within 10 min of cessation of exposure to HBO.
Pathology of Oxygen Toxicity
The pathology of oxygen toxicity has been documented comprehensively in a classical work on this topic (Balentine 1982) . The various manifestations of O:A")'gen poisoning are summarized in Figure 6 .2. It is well known that the development of pulmonary and CNS toxicity depends upon the partial pressure and the duration of exposure, as shown in Figure 6 .3. Fortunately, the early effects of poisoning are completely reversible, but prolonged expo~ Individual variation in susceptibility to oxygen poisoning. Curves designated as pulmonary limits are inspired pOz exposure duration relationships for occurrence of one or more neurologic signs and symptoms listed in sure first lengthens the recovery period and then eventually produces irreversible changes. Many organs have been affected in experimental oxygen toxicity studies of long exposure to high pressures -a situation that is not seen in clinical practice. High-pressure oxygen leads to increased pyruvate/lactate and pyruvate malate redox couples, as well as to a decrease in the incorporation of phospholipid long-chain fatty acid and pyruvate into the tissue lipid. During recovery from the effects of high-pressure oxygen these changes are reversed. These data indicate that m,"ygenpoisoning of tissues is not the result of an inhibition of carbohydrate metabolism, but instead may result from the formation of toxic lipoperoxides.
Thepower expression for cumulative oxygen toxicity and theexponential recovery have been successfully applied to rariousfeaturesof oxygen toxicity at the Israel Naval Medical Institutein Israel (Arieli et a/2002) . From the basic equation, theauthorsderived expressions for a protocol in which P02 changeswith time. The parameters of the power equation weresolvedby using nonlinear regression for the reduction inritalcapacity (Delta VC) in humans: OeltaVC = 0.0082 x tz (POz/101.3) (4.57) wheret is the time in hours and P02 is expressed in kPa.
Therecovery of lung volume is:
IJdtaVC(t) = DeltaVC(e) x e(-(-Q.42 + 0.00379 POz)t) whereDdtaVC(t) is the value at time t of the recovery, DeltaVC(e) is the value at the end of the hyperoxic exposure, andPO! is the prerecovery oxygen pressure.
Datafrom different experiments on CNS oxygen toxicity inhumansin the hyperbaric chamber were analyzed along withdatafrom actual closed-circuit oxygen diving by using a maximum likelihood method. The parameters of the modelwere solved for the combined data, yielding the power equation for active diving:
I,"here t is in minutes.
Itwassuggested that the risk of CNS oxygen toxicity in diringcan be derived from the calculated parameter of the normal distribution: Therecoverytime constant for CNS oxygen toxicity was calculated from the value obtained for the rat, taking into account the effect of body mass, and yielded the recovery cquation: (-0.079t) \·;here K(t) and K(e) are the values of K at time t of the rccorcrrprocess and at the end of the hyperbaric oxygen cxposure, respectively, and t is in minutes.
Pulmonary Oxygen Toxicity
Thisis usually a manifestation of prolonged exposure Imurethan 24 h) to normobaric 100% oxygen, as well as duringexposure to HBO from 2 to 3 ATA O2 in human andexperimental animals. The pathology and pathophysiologrof pulmonary oxygen toxicity are described in moredetail elsewhere (Jain 1989b). The major mechanismbr which HBO produces lung injury in rabbits is by stimUlating thromboxane synthesis. Lung injury induced byiree radicalshas been demonstrated in an animal moddoismokeinhalation, and the free radicals clear up after about an hour. Normobaric 100% oxygen given for one hour does not increase the level of free radicals in this model, but HBO at 2.5 ATA does so.
Acute changes in the lungs resulting from oxygen toxicity consist of alveolar and interstitial edema, alveolar hemorrhages, and proteinaceous exudates. This is followed by an inflammatory reaction. Further prolonged exposure to oxygen leads to a proliferative phase, which includes proliferation of type II epithelial cells and fibroblasts, followed by collagen deposits. Healing may occur after discontinuance of oxygen exposure, but areas of fibrosis and emphysema may remain. In patients with heart failure or in patients with reduced cardiac ejection fractions, HBO may contribute to pulmonary edema by increasing left ventricular afterload, increasing oxidative myocardial stress, decreasing left ventricular compliance by oxygen radical-mediated reduction in nitric oxide, increasing pulmonary capillary permeability, or by causing pulmonary oxygen toxicity (Weaver & Churchill 2001) .
Repeated exposure to HBO at intervals insufficient to allow total recovery from pulmonary oxygen toxicity may lead to cumulative effects. The progression of toxicity can be monitored by serial pulmonary function studies. The concept of a "unit pulmonary toxic dose" (UPTD) has been developed (Bardin & Lambertsen 1970), and this allows comparison of the pulmonary effects of various treatment schedules of HBO (Table 6 .2). The UPTD is designed to express any pulmonary toxic dose in terms of an equivalent exposure to m:ygen at 1 ATA. It is only an arbitrary measure and does not allow for the recovery between HBO exposures. For example, 10 HBO treatments at 2.4 ATA for 90 min each would give the patient a UPTD of more than 200 and would indicate significant pulmonary toxicity with a 20% reduction in vital capacity. In practice, however, no clinical evidence of pulmonary toxicity is seen with this schedule. There is no significant impairment of pulmonary diffusing capacity in divers who have been intermittently exposed to HBO at 4 ATA for years.
Prolonged exposure to elevated oxygen levels is a frequent and important clinical problem. Superoxide dismutase (SOD) and catalase, the major intracellular antioxidant enzymes, cooperate in the detoxification of free oxygen radicals produced during normal aerobic respiration. Therapeutic approaches designed to deliver SOD or catalase to these intracellular sites would be useful in mitigating the pulmonary oxygen toxicity. A number of approaches to deliver these enzymes have not been successful. Adenovirus-mediated transfer to lungs of both catalase and SOD cDNA has been shown to protect against pulmonary oxygen toxicity. Distal airway epithelial cells, including type II alveolar and nonciliated bronchiolar epithelial cells, are important targets for oxygen radicals under the hyperoxic condition. The accessibility of these distal airway epithelial cells to in vivo gene transfer through the tracheal route of administration, suggests the 
Factors that Enhance Oxygen Toxicity
Various factors which enhance oxygen toxicity are listed in Table 6 .3. Combining HBO with the substances listed, together with morbid conditions such as fever, should definitely be avoided. Mild hyperthermia (38.5 DC)has been used therapeutically for a number of conditions. An increase of temperature increases oxygen uptake by body tissues. Hyperthermia may thus be expected to enhance oxygen toxicity. Transient biochemical side effects of mild hypothermia such as hyperammonemia can be inhibited by HBO, but this combination should be used cautiously to avoid oxygen toxicity.
It is generally believed that high humidity enhances oxygen toxicity as manifested by lung damage and convulsions. This has been experimentally verified in rodents exposed to HBO (515 to 585 kPa) under conditions of low humidity as well as 60% relative humidity.
Physical exercise definitely lowers the threshold for CNS oxygen toxicity in the rat over the entire range of pressures from 2 to 6 ATA.This observation should be kept in mind in planning physical exercise in hyperbaric environments (see Chapter 4). Various enzymes inhibited by hyperoxia are shown in Table 6 .4. This may explain how hyperoxia leads to oxygen toxity.
GlutdChione reductase is an integra! component of the antioxidant defence mechanism. Inhibition of brain glutathione reductase by carmustine lowers the threshold for seizures in rats exposed to HBO. 
Oxygen-Induced Retinopathy
Retrolental fibroplasia is considered to be an oxygen-induced obliteration of the immature retinal vessels when 100% oxygen is given to premature infants. A recent study showed that oxygen therapy for more than 3 days, in infants delivered following 32-36 weeks of gestation, was not associated with an increased risk of retinopathy of prematu- 
Effect on Cerebral Metabolism
Disturbances of cerebral metabolism resulting from hyperoxia have been described in Chapter 2. HBO at 2 ATAhas been shown to stimulate rCMRGI slightly, but does not result in any toxic manifestations. Oxidative metabolism of the brain is usually not affected by pressures up to 6 ATA. In the primary rat cortical culture, HBO exposure to 6 ATA for 30, 60, and 90 min increased the lactate dehydrogenase (LDH) activity in the culture medium in a time-dependent manner (Huang et al 2000) . Accordingly, the cell survival was decreased after HBO exposure. Pretreatment with the NMDA antagonist MK-801 protected the cells against the HBO-induced damage. The protective effect was also noted in the cells pretreated with L-N(G)-nitro-arginine methyl ester, an NO synthase inhibitor. These results suggest that activation of NMDA receptors and production of NO play a role in the neurotoxicity produced by HBO exposure. There is no evidence that seizures are related to oxidative metabolic changes. However, increase of glucose utilization precede the onset of electrophysiological manifestations of CNS oxygen toxicity). Increased nitric oxide (NO) production during prolonged HBO exposure is responsible for escape from hyperoxic vasoconstriction in cerebral blood arterioles. The finding suggests that NO overproduction initiates CNS oxygen toxicity by increasing rCBF,which allows excessive oxygen to be delivered to the brain (Demchenko et al 2001). The hypothetical pathophysiologic pathways leading to acute and chronic CNS oxygen toxicity are illustrated in Figure 6 .4.
Effect on Neurotransmitters
Neurotransmitters have been shown to be downregulated under hyperbaric hyperoxia (Courtiere et al1991). With the recognition of nitric oxide (NO) as a neurotransmitter, its relationship to hyperia has been studied. Experimental studies of Zhang et al (1993) showed that rats can be protected against oxygen toxicity by a combination of a monoamine oxidase inhibitor and a nitric oxide (NO) synthase inhibitor. Their data showed that protection against oxygen toxicity by these agents is not related to the preservation of the GABA pool. They found that oxygen-dependent noradrenaline metabolism and NO synthesis appear to be inactive during oxygen neurotoxicity. Oury et al (1992) consider NO to be an important mediator in oxygen neurotoxicity and suggest that extracellular superoxide dismutase increases oxygen neurotoxicity by inactivation of NO.
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Ammoniaand Amino Acids
Single seizures induced in rats subjected to HBO at 6 ATA haw heen shown to be associated with accumulation of ammoniaand alterations in amino acids in the brain, with lht greatestchanges taking place in the striatum (Mialon ,·t IlJ 1992). These changes were considered to be caused by anincreasein oxidative deamination or possibly the result ofgliallililureto capture released amino acids. The subseIlutnlimbalancebetween the excitatory and inhibitory mediatorsin the striatum was offered as an explanation of the rtcurrenceof seizures in animals maintained on HBO.
Changes in the Electrical Activity of the Brain andSeizures
Ctlnscious rats and rabbits exposed to HBO usually demon-,Iratean increased EEG slow wave activity which eventually dmlops into bursts of paroxysmal electrical discharges. Theseelectricalevents precede the onset of visible HBO-inducedconvulsions,and therefore were suggested as an early ,igm of CNS oxygen toxicity in experimental animals. In \'itw studieswith HBO also show changes in neuronal electrical activity, which may be associated with seizures. Theseizure associated with HBO usually occurs toward lheend of the o},l'gen exposure while the patient is being dWlIllpressed. It is a violent motor discharge with a brief rtriod of breathholding. In such cases, therefore, decomprmioll should be temporarily halted until the seizure is om; otherwise there could be rupture of lung alveoli. Epileps)' has been listed as a contraindication for using HBO therapy. This is based on the assumption that oxygen is liable to precipitate a seizure in an epileptic patient and such an event in a chamber might be detrimental to the patient. Seizures in epileptic patients are rare during HBO therapy where pressures less than 2 ATA are used. There is no published study that reexamines this issue. The question therefore still arises: is HBO really dangerous for an epileptic? If epilepsy is included in the contraindications for HBO, patients with head injuries and strokes who happen to have seizures would be deprived of the benefit of HBO therapy. The mechanism of epilepsy in such patients is different from that of an m."ygen-induced convulsion. It has even been shown that EEG abnormalities in stroke patients improve with HBO treatment (Wassmann 1980) . It is possible that HBO may abort a seizure from a focus with circulatory and metabolic disturbances by correcting these abnormalities. Seizures are extremely rare and no more than a chance occurrence during HBO sessions at pressures between 1.5 and 2 ATA even in patients with a history of epilepsy.
Neuropathology
In experimental studies, there is no damage to the CNS of rats exposed to HBO until the pressure exceeded 4 ATA. The brain damage is increased by CNS-depressant drugs, increase of pCOl, acetazolamide, and NH4Cl. Permanent spastic limb paralysis has been observed in rats (the John Bean effect) after repeated exposure to high oxygen pressures (over 5 ATA). There is selective necrosis of white matter both in the spinal cord and the brain, and this is considered to be the effect ofhyperoxia. HBO-induced rat brain lesions, examined by electron microscopy, show two types of nerve cell alterations: (I) type A lesions characterized by pyknosis and hyperchromatosis of the nerve cells, vacuolization of the cytoplasm, and simultaneous swelling of the perineural glial processes; (2)type B lesions are characterized by lysis in the cytoplasm and karyorrhexis.
Manifestations of CNS Oxygen Toxicity
Signs and symptoms of CNS m.]'gen toxicity are listed in Table 6 .5.
Clinical Monitoring for Oxygen Toxicity
The most important factor in early detection of oxygen toxicity is the observation of signs and symptoms. For monitoring pulmonary function, determination of vital capacity is the easiest and most reliable parameter, as it is reduced before any irreversible changes occur in the lungs. EEG tracings do not show any consistent alterations before the onset of seizures and are not a reliable method of early detection of oxygen toxicity. Decrease in [9,10-3H] oleic acid incorporation by human erythrocytes detected ill vitro after HBO exposure ill vivo may reflect an early event in the pathogenesis of m.:ygen-induced cellular injury and may be a useful monitoring procedure.
An increase in CBF velocity (BCFV) precedes onset of symptoms of oxygen toxicity during exposure to 280 kPa oxygen, which may be followed by seizure (Koch et al 2008) . At rest a delay of approximately 20 min precedes the onset of CNS oxygen toxicity and seizure can be aborted with timely oxygen reduction. 
Protection Against Oxygen Toxicity
Various agents and measures for prevention or treatment of oxygen toxicity are listed in Table 6 .6; these are mostly experimental. The most promising agents are the antioxidants. The use of vitamin E (tocopherol) is based on the free-radical theory of oxygen toxicity. It has been used to protect premature infants (who lack vitamin E) against oxygen toxicity. Dietary suppJementation with selenium and vitamin E, which increase the cerebral as well as extracerebral GSH content, does not protect rats against the effect of HBO by delaying the onset of first electrical discharge (Boadi et al1991) . However, such diets may still be advantageous in promoting recovery and reversal of toxic process, as occurs between consecutive HBO exposures or during intermittent oxygen exposure (Bleiberg & Kerem 1988) .
Not all of the dietary free-radical scavengers are effective in counteracting oxygen toxicity. In animal experiments, no correlation was found between ill vitro inhibition of lipid peroxidation and ill vivo protection against oxygen toxicity. Hypothermia has been considered to be a protector against o},.}'gentoxicity, but HBO at 5 ATA induces hypothermia in mice, and this has little protective effect against convulsions.
Every clinician who treats patients should be aware of oxygen toxicity, although it is rare. At pressures of 1.5 ATA,even prolonged use in patients with cerebrovascular disease has not led to any reported case of oxygen toxicity. It should not be assumed that experimental observations regarding oxygen toxicity under hyperbaric conditions are· applicable to normobaric conditions. \\'hereasdisulfiram protects against hyperbaric oxygen, it potentiatesthe toxicity of normobaric oxygen in rats. AsCorhicacid is also a free radical scavenger and protects againstoxygen toxicity, but large doses of this vitamin mayprovecounterproductive in treating oxygen toxicity if the reducing enzymes are overloaded. An oxidized ascorbatemight actually potentiate oxygen toxicity through lipoperoxideformation. Mg2+ has a double action against theundesirable effects of oxygen. It is a vasodilator and ailoa calciumblocker and protects against cellular injury. \Iagnesium sulfate suppresses the electroencephalographicmanifestations of CNS oxygen toxicity and an antiConvulsant effect has been demonstrated in rats exposed to HBO at 6ATA. A prophylactic regimen of 10 mmol \Ig" 3h bd(m a session of HBO and 400 mg of vitamin EJaily,starting a couple of days before the HBO treatment,is useful in preventing oxygen toxicity, but no controlledstudy has been done to verify the efficacy of this regime.
Thedetoxit)'ing function of cytochrome c to scavenge ROS in mitochondria has been confirmed experimentally 1,\lin& Jian-xing 2007). A concept of mitochondrial radicalmetabolism is suggested based on the two electronleakpathwaysmediated by cytochrome c that are metabolicroutes of oxygen free radicals. The main portion of oxygenconsumed in the electron transfer of respiratory chainis used in ATP synthesis, while a subordinate part lit' oxygenconsumed by the leaked electrons contributes 10 ROS generation. The models of respiratory chain opmting with two cytochrome c-mediated electron-leak pathways and a radical metabolism of mitochondria accnmpaniedwith energy metabolism are helpful in underItandingthe pathological problems caused by oxygen toxicity Distalairway epithelial cells, including type II alveolar Jndnonciliatedbronchiolar epithelial cells, are important targebI()r0~radicals under the hyperoxic condition. The Jccessibility of these distal airway epithelial cells to in vivo genetransfer through the tracheal route of administration, suggeststhe potential for in vivo transfer of MnSOD andextracellularSOD genes as a future approach in the preventionof pulmonary O2 toxicity (Tsan 2001).
Extension of Oxygen Tolerance
"!ll!erance to oxygenprimarily means tolerance to the toxic efli:cts, becausethe physiological effects have no prolonged COIMjUeI1Ces. This subject has been discussed in detail by LJmbertsen(1988) . He considers a positive emphasis on eX!ending oxygen tolerance as desirable, as opposed to a reltrictirefear of oxygen poisoning. The following are compikdfrom his comments regarding extension of oxygcntolerance.
Tolerance Extension by Adaptation
At low levels of atmospheric hyperoxia, some forms of true protective adaptation appear to occur, such as that related to changing antioxidant defenses in some tissues. At higher oxygen pressures, some adaptation could conceivably occur in some cells of the intact human being with progressive and severe poisoning in other cells. At very high oxygen pressure, rapid onset of poisoning would make adaptation inadequate and too late.
Tolerance Extension by Drugs
A pharmacological approach, such as that of providing free radical scavengers, will attain broad usefulness only if the drug can attain the free permeability of the oxygen molecule. The drug should reach the right location at the right time, and remain effective there in the face of continuous hyperoxia, without itself inducing any toxic effects. There is no such ideal drug available at present.
Tolerance Extension by Interrupted Exposure to Oxygen
Interruption of exposure to HBO is known to extend the safe exposure time. In experimental animals, intermittent exposure to HBO postpones the gross symptoms of oxygen toxicity along with changes in enzymes, such as superoxide dismutase, in the lungs (Harabin et aI1990) . Species differences were noted in this study; biochemical variables were more pronounced in guinea pigs than in rats.
There is no accepted procedure for quantifying the recovery during normoxia. A cumulative oxygen toxicity index -K, when K reaches a critical value (Kc) and the toxic effect is manifested, can be calculated using the following equation:
where t(e) is hyperoxic exposure time and POz is oxygen pressure and c is a power parameter.
Recovery during normoxia (reducing K) is calculated by the following equation K2 = K. x e[-rt(r)J where t(r) is recovery time, r being the recovery time constant.
A combination of accumulation of oxygen toxicity and its recovery can be used to calculate central nervous system oxygen toxicity. Predicted latency to the appearance of the first electrical discharge in the electroencephalogram, which precedes clinical convulsions, was compared to mea-58 Chapter 6 sured latency for seven different exposures to HBO, followed by a period of normoxia and further HBO exposure (Arieli & Gutterman 1997). Recovery followed an exponential path, with r = 0.31 (SD 0.12) min (-1). Calculation of the recovery of the CNS oxygen toxicity agreed with the previously suggested exponential recovery of the hypoxic ventilatory response and was probably a general recovery process. The authors concluded that recovery can be applied to the design of various hyperoxic exposures.
Inclusion of air breaks in prolonged HBO treatment schedules is a recognized practice. The return to normobaric air between HBO sessions may lead to low pOz seizures, which are also described as a "switch off' phenomenon. However, much research still needs to be done to find the ideal schedules to extend oxygen tolerance.
Effect of HBO on the CNS of Newborn Mammals
Newborn mammals are extremely resistant to the CNS effects of HBO compared to adults. Indirect evidence indicates that HBO in newborn rats induces a persistent cerebral vasoconstriction concurrently with a severe and maintained reduction in ventilation.
The outcome of these exposures may be as follows:
• Extension of tolerance to both CNS and pulmonary oxygen toxicity, • Creation of a hypoxic-ischemic condition in vulnerable neuronal structures, and
• Impairment of circulatory and ventilatory responses to hypoxic stimuli on return to air breathing, with subsequent development of a hypoxic-ischemic condition.
These events may set the stage for development of delayed neurological disorders.
Conclusion and Directions for Future Research
The exact mechanism underlying oxygen toxicity to the CNS is not known, but the free radical theory appears to be the most likely explanation. The role of nitric oxide in the effect of HBO has also been established. Fortunately, CNS oxygen toxicity is rare because most HBO treatments are carried out at pressures below 2.5 ATA, and the duration of treatment does not exceed 90 min. Nevertheless, a physician treating patients with HBO must be aware of oxygen toxicity. There is no rational prevention or treatment, but free radical scavengers are used in practice to prevent the toxic effects of oxygen. Until a better understanding of the mechanism of oxygen toxicity and better methods of treatment are available, use of the free radical scavengers that are available appears to be a reasonable practice, particularly when these are relatively nontoxic. In situations where prolonged exposures to HBO are required, the benefits of treatment versus the risks of oxygen toxicity should be carefully weighed. The chemiluminescence index, which is a measure of tissue lipid peroxidation indicates individual sensitivity of the body to HBO. Such a technique would enable the prediction of the effectiveness of HBO treatment as well as control its duration. Oxygen toxicity can also be exploited for therapeutic purposes. One example of this is the use of HBO as an antibiotic. Induced oxygen toxicity by HBO with protection of the patient by free radical scavengers should be investigated as an adjunctive treatment for AIDS, because the virus responsible for this condition has no protective mechanisms against free radicals. Since induction of antioxidative defence mechanisms has been determined after HBO exposure, a modified treatment regimen of HBO therapy may avoid genotoxic effects (Speit et a12002).
The methods for estimating free radicals are still cumbersome and not in routine use. More practical methods should be developed as a guide to the safe limits ofHBO therapy.
The molecular basis of oxygen toxicity should be sought at the cellular and organelle levels. Simultaneous monitoring of cerebral, electrical, circulatory, and energy-producing functions is a useful tool for determining the safety margins of HBO, as well as for tracing the primary mechanisms of oxygen toxicity in the CNS.
Mammalian cell lines have been shown to develop tolerance to oxygen by repetitive exposure to HBO at 6 to 10 ATA for periods up to 3 h. Repeated screening of various cell lines may lead to the discovery of oxygen-resistant cell types, which might provide an insight into the factors inherent in the development of oxygen tolerance.
The latest approach to counteract pulmonary oxygen toxicity is gene therapy by viral-mediated transfer SOD and catalase to the pulmonary epithelium. This appears to be the most promising method of delivery of these enzymes.
